The Metabolic Syndrome in Older Individuals: Prevalence and Prediction of Cardiovascular Events
The Cardiovascular Health Study*
- Angelo Scuteri, MD, PHD12,
- Samer S. Najjar, MD1,
- Christopher H. Morrell, PHD1 and
- Edward G. Lakatta, MD1
- 1Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland
- 2Unità Operativa Geriatria, Istituto Nazionale Ricovero E Cura Anziari, Rome, Italy
- Address correspondence and reprint requests to Angelo Scuteri, MD PhD, Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Dr., Baltimore, MD 21224. E-mail: scuteria{at}mail.nih.gov
Abstract
OBJECTIVE—The prevalence of the metabolic syndrome, a potent risk factor for cardiovascular diseases (CVDs), has not been adequately explored in older individuals. Moreover, two sets of criteria have been proposed for the definition of metabolic syndrome, one by the World Health Organization (WHO) and one by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). We therefore investigated the prevalence of this syndrome in a subgroup of older participants from the Cardiovascular Health Study (CHS) who were free of CVD at baseline. We also compared the prognostic significance of the two definitions of the metabolic syndrome.
RESEARCH DESIGN AND METHODS—A total of 2,175 subjects from the CHS who were free of CVD at baseline and not taking antihypertensive or lipid-lowering medications were studied. Prevalence of the metabolic syndrome was assessed with both the WHO and ATPIII criteria. The incidence of coronary or cerebrovascular disease was ascertained during a median follow-up time of 4.1 years.
RESULTS—Prevalence of the metabolic syndrome was 28.1% by ATPIII criteria and 21.0% by WHO criteria. The two sets of criteria provided concordant classification for 80.6% of participants. Multivariate Cox propotional hazard models showed that the metabolic syndrome defined with the ATPIII criteria, but not with the WHO criteria, was an independent predictor of coronary or cerebrovascular events and was associated with a 38% increased risk (hazard ratio 1.38 [95% CI 1.06–1.79], P < 0.01).
CONCLUSIONS—Prevalence of the metabolic syndrome in older individuals is ∼21–28% (depending on the definition used). The two sets of criteria have 80% concordance in classifying subjects. As defined by the ATPIII criteria, the metabolic syndrome yields independent prognostic information, even after adjusting for traditional cardiovascular risk factors and the individual domains of the metabolic syndrome.
- AUC, area under the curve
- CeVD, cerebrovascular disease
- CHD, coronary heart disease
- CHS, Cardiovascular Health Study
- CVD, cardiovascular disease
- IMT, intima-media thickness
- NCEP ATPIII, National Cholesterol Education Program Adult Treatment Panel III
- WHO, World Health Organization
Footnotes
- *
↵* A complete list of the participating Cardiovascular Health Study investigators and institutions can be found in the appendix.
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted January 10, 2005.
- Received October 26, 2004.
- DIABETES CARE














